期刊文献+

左室射血分数、血管生成素2与慢性心力衰竭预后的相关性 被引量:4

Correlation between left ventricular ejection fraction, angiopoietin 2 and prognosis of chronic heart failure
下载PDF
导出
摘要 目的研究左室射血分数(LVEF)、血管生成素2(Ang-2)与慢性心力衰竭(CHF)预后的相关性,以期为有效评估CHF患者预后提供有效指标。方法将2013年1月~2015年1月于河北省人民医院接受诊治的CHF患者129例为研究对象,对所有患者均进行为期3年的随访,根据随访结果将其分为生存组98例与死亡组31例。分别比较两组患者年龄、性别、体质指数(BMI)、糖尿病、高血压与心肌梗死等基本资料,收缩压、舒张压、LVEF、Ang-2及利钠肽(NP)等生化指标水平,并作多因素Logistic回归分析。结果与死亡组相比,生存组性别、年龄、BMI、糖尿病、高血压、心肌梗死差异无统计学意义(P均>0.05)。生存组收缩压、Ang-2、NP水平分别为(140.02±6.30)mmHg、(5.69±0.30)pg/ml、(2.70±0.28)pg/ml,低于死亡组的(145.05±6.11)mmHg、(5.92±0.17)pg/ml、(2.94±0.13)pg/ml,而LVEF为(47.54±3.97)%,高于死亡组的(43.29±3.27)%,差异均有统计学意义(P均<0.05)。经多因素Logistic回归分析,Ang-2是CHF死亡的独立危险因素,而LVEF是保护性因素(P均<0.05)。结论临床工作中可通过联合检测LVEF与Ang-2水平,对CHF患者的预后进行有效的评估。 Objective To study the correlation between left ventricular ejection fraction(LVEF)and angiopoietin 2(Ang-2)and the prognosis of chronic heart failure(CHF)with a view to providing effective indicators for the effective evaluation of the prognosis of patients with CHF.Methods 129 CHF patients treated in Hebei People's Hospital from January 2013 to January 2015 were selected as the research subjects.According to the follow-up results,they were divided into survival group(98 patients)and death group(31patients).The basic data of all patients,such as age,sex,body mass index(BMI),diabetes history,history of hypertension,and the history of myocardial infarction,systolic pressure,diastolic pressure,LVEF,Ang-2 and natriuretic peptide(NP)was compared.Results Compared with the death group,there was no significant difference in gender,age,BMI,history of diabetes,history of hypertension,and history of myocardial infarction in the survival group(all P>0.05).The systolic blood pressure,Ang-2,and NP levels in the survival group were(140.02±6.30)mmHg,(5.69±0.30)pg/ml,(2.70±0.28)pg/ml,which was lower than that of the death group(145.05±6.11)mmHg.(5.92±0.17)pg/ml,(2.94±0.13)pg/ml,and LVEF was(47.54±3.97)%,which was higher than death group(43.29±3.27)%,the difference was statistically significant(both P<0.05).After multivariate logistic regression analysis,Ang-2 was an independent risk factor for CHF death,while LVEF was a protective factor(both P<0.05).Conclusion Clinically,the prognosis of CHF patients can be effectively evaluated by jointly detecting LVEF and Ang-2 levels.
作者 王立立 耿彦平 杜荣品 Wang Lili;Geng Yanping;Du Rongping(Department of Cardiology,Hebei People's Hospital,Shijiazhuang 050051,China)
出处 《中国循证心血管医学杂志》 2018年第12期1500-1502,共3页 Chinese Journal of Evidence-Based Cardiovascular Medicine
基金 河北省医学科学研究重点课题计划(20180032)
关键词 慢性心力衰竭 左室射血分数 血管生成素2 预后评估 Chronic heart failure Left ventricular ejection fraction Angiogenin 2 Prognosis assessment
  • 相关文献

参考文献18

二级参考文献174

  • 1Muhammad Asrar ul Haq,Chiew Wong,Vivek Mutha,Nagesh Anavekar,Kwang Lim,Peter Barlis,David L Hare.Therapeutic interventions for heart failure with preserved ejection fraction:A summary of current evidence[J].World Journal of Cardiology,2014,6(2):67-76. 被引量:7
  • 2王方正,张澍,黄德嘉,华伟,孙宝贵,沈法荣,吴书林,王建安,方全,吴立群,王景峰,王冬梅,郭涛,陈新,中华医学会心电生理和起搏分会心脏再同步治疗专家工作组.心脏再同步治疗慢性心力衰竭的建议[J].中华心律失常学杂志,2006,10(2):90-102. 被引量:90
  • 3顼国华,周晓芳.老年性心衰治疗进展[J].老年医学与保健,2007,13(2):124-127. 被引量:4
  • 4Colucci WS. Molecular and cellular mechanisms of myocardial failure. Am J Cardiol, 1997, 80(11A) : 15L-25L 被引量:1
  • 5Braunwald E,Bristow MR Congestive heart failure: fifty years of progress. Circulation, 2000, 102(20 Suppl 4) : Ⅳ14-23. 被引量:1
  • 6Hunt SA, Abraham WT, Chin MH, et al. ACC/AHA 2005 Guideline Update for the Diagnosis and Management of Chronic Heart Failure in the Adult: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Update the 2001 Guidelines for the Evaluation and Management of Heart Failure) : developed in collaboration with the American College of Chest Physicians and the International Society for Heart and Lung Transplantation: endorsed by the Heart Rhythm Society. Circulation, 2005, 112 (12) :e154-235. 被引量:1
  • 7Swedberg K, Cleland J, Dargie H, et al. Guidelines for the diagnosis and treatment of chronic heart failure: executive summary ( update 2005 ):The Task Force for the Diagnosis and Treatment of Chronic Heart Failure of the European Society of Cardiology. Eur Heart J, 2005, 26(11): 1115-1140. 被引量:1
  • 8Arnold JM, Liu P, Demers C, et al. Canadian Cardiovascular Society consensus conference recommendations on heart failure 2006 : diagnosis and management. Can J Cardiol, 2006, 22 (1): 23-45. 被引量:1
  • 9Heart Failure Society of America. HFSA 2006 Comprehensive Heart Failure Practice Guideline. J Card Fail, 2006, 12 ( 1 ) : e1-2. 被引量:1
  • 10Enright PL, Sherrill DL Reference equations for the six-minute walk in healthy adults. Am J Respir Crit Care Med, 1998, 158(5 pt 1) :1384-1387. 被引量:1

共引文献4020

同被引文献34

引证文献4

二级引证文献6

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部